Keith G. Tolman

4.2k total citations
83 papers, 3.2k citations indexed

About

Keith G. Tolman is a scholar working on Pharmacology, Surgery and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Keith G. Tolman has authored 83 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pharmacology, 19 papers in Surgery and 16 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Keith G. Tolman's work include Drug-Induced Hepatotoxicity and Protection (15 papers), Pharmacological Effects and Toxicity Studies (12 papers) and Drug Transport and Resistance Mechanisms (11 papers). Keith G. Tolman is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (15 papers), Pharmacological Effects and Toxicity Studies (12 papers) and Drug Transport and Resistance Mechanisms (11 papers). Keith G. Tolman collaborates with scholars based in United States and United Kingdom. Keith G. Tolman's co-authors include Anthony Dalpiaz, Vivian Fonseca, Meng H. Tan, Randall G. Lee, Steven W. Sanders, Joel M. Kremer, James W. Freston, Phillip D. Gray, William Jubiz and Kenneth N. Buchi and has published in prestigious journals such as Annals of Internal Medicine, Gastroenterology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Keith G. Tolman

82 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keith G. Tolman United States 31 803 669 632 466 454 83 3.2k
Richard A. Robson New Zealand 29 489 0.6× 513 0.8× 323 0.5× 480 1.0× 388 0.9× 87 2.8k
G Strohmeyer Germany 35 1.3k 1.7× 1.2k 1.8× 444 0.7× 909 2.0× 223 0.5× 193 5.8k
S B Rosalki United Kingdom 26 442 0.6× 481 0.7× 499 0.8× 510 1.1× 293 0.6× 99 2.7k
Norton J. Greenberger United States 30 843 1.0× 950 1.4× 256 0.4× 358 0.8× 139 0.3× 86 3.0k
J. Waldenström Sweden 21 432 0.5× 499 0.7× 389 0.6× 725 1.6× 150 0.3× 73 3.7k
Eero A. Sotaniemi Finland 28 502 0.6× 276 0.4× 418 0.7× 592 1.3× 947 2.1× 128 2.7k
Burton Combes United States 37 1.6k 2.0× 652 1.0× 344 0.5× 529 1.1× 703 1.5× 114 4.1k
Yves Horsmans Belgium 29 852 1.1× 394 0.6× 161 0.3× 401 0.9× 439 1.0× 93 2.3k
Nicola Carulli Italy 34 2.1k 2.6× 1.4k 2.0× 805 1.3× 618 1.3× 205 0.5× 115 4.1k
Nils Tryding Sweden 22 335 0.4× 458 0.7× 352 0.6× 694 1.5× 131 0.3× 75 2.9k

Countries citing papers authored by Keith G. Tolman

Since Specialization
Citations

This map shows the geographic impact of Keith G. Tolman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith G. Tolman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith G. Tolman more than expected).

Fields of papers citing papers by Keith G. Tolman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith G. Tolman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith G. Tolman. The network helps show where Keith G. Tolman may publish in the future.

Co-authorship network of co-authors of Keith G. Tolman

This figure shows the co-authorship network connecting the top 25 collaborators of Keith G. Tolman. A scholar is included among the top collaborators of Keith G. Tolman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith G. Tolman. Keith G. Tolman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tolman, Keith G.. (2011). The safety of thiazolidinediones. Expert Opinion on Drug Safety. 10(3). 419–428. 39 indexed citations
2.
Tolman, Keith G., Vivian Fonseca, Anthony Dalpiaz, & Meng H. Tan. (2007). Spectrum of Liver Disease in Type 2 Diabetes and Management of Patients With Diabetes and Liver Disease. Diabetes Care. 30(3). 734–743. 412 indexed citations
3.
4.
Benson, Gordon D., Raymond S. Koff, & Keith G. Tolman. (2005). The Therapeutic Use of Acetaminophen in Patients with Liver Disease. American Journal of Therapeutics. 12(2). 133–141. 90 indexed citations
5.
Tolman, Keith G., et al.. (2003). Hepatotoxicity of the thiazolidinediones. Clinics in Liver Disease. 7(2). 369–379. 94 indexed citations
6.
Tolman, Keith G.. (2000). Defining patient risks from expanded preventive therapies. The American Journal of Cardiology. 85(12). 15–19. 79 indexed citations
7.
Tolman, Keith G.. (2000). Eicosanoids and the liver. Prostaglandins & Other Lipid Mediators. 61(3-4). 163–174. 8 indexed citations
8.
Tolman, Keith G.. (1998). Hepatotoxicity of non-narcotic analgesics. The American Journal of Medicine. 105(1). 13S–19S. 70 indexed citations
9.
Vance, M.A., Phillip D. Gray, & Keith G. Tolman. (1994). Effect of Glycine on Valproate Toxicity in Rat Hepatocytes. Epilepsia. 35(5). 1016–1022. 10 indexed citations
10.
Walker, Alexander M., Donnie Funch, Nancy A Dreyer, et al.. (1993). Determinants of serious liver disease among patients receiving low‐dose methotrexate for rheumatoid arthritis. Arthritis & Rheumatism. 36(3). 329–335. 141 indexed citations
11.
Sanders, Steven W., Keith G. Tolman, & Donald P. Reitberg. (1992). Effect of a single dose of lactase on symptoms and expired hydrogen after lactose challenge in lactose-intolerant subjects.. PubMed. 11(6). 533–8. 20 indexed citations
12.
Mazer, Norman A., A.W. Meikle, John D. Stringham, et al.. (1992). Enhanced transdermal delivery of testosterone: a new physiological approach for androgen replacement in hypogonadal men. Journal of Controlled Release. 19(1-3). 347–361. 36 indexed citations
13.
Sanders, Steven W., et al.. (1992). Circadian differences in pharmacological blockade of meal‐stimulated gastric acid secretion. Alimentary Pharmacology & Therapeutics. 6(2). 187–193. 8 indexed citations
14.
Sanders, Steven W., et al.. (1992). The effects of lansoprazole, a new H+,K+‐ATPase inhibitor, on gastric pH and serum gastrin. Alimentary Pharmacology & Therapeutics. 6(3). 359–372. 49 indexed citations
15.
Sanders, Steven W., et al.. (1991). Pharmacokinetics and tolerance of a cholesteryl sulfate complex of amphotericin b abcd administered to healthy volunteers. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 11(3). 268. 1 indexed citations
16.
Ferrero, J L, Barbara A. Bopp, Kennan C. Marsh, et al.. (1990). Metabolism and disposition of clarithromycin in man.. Drug Metabolism and Disposition. 18(4). 441–446. 97 indexed citations
17.
Tolman, Keith G., et al.. (1989). Toxicity of uricosuric diuretics in rat hepatocyte culture. Biochemical Pharmacology. 38(7). 1181–1184. 3 indexed citations
18.
Bjorkman, David J., Randall W. Burt, & Keith G. Tolman. (1988). Primary Care of Women with Gastrointestinal Disorders. Clinical Obstetrics & Gynecology. 31(4). 974–988. 4 indexed citations
19.
Moore, John G., et al.. (1986). The effect of oral potassium chloride on upper gastrointestinal mucosa in healthy subjects: healing of lesions despite continuing treatment. Gastrointestinal Endoscopy. 32(3). 210–212. 7 indexed citations
20.
Sennello, Lawrence T., Richard A. Finley, Sou-Yie Chu, et al.. (1986). Single-Dose Pharmacokinetics of Leuprolide in Humans Following Intravenous and Subcutaneous Administration. Journal of Pharmaceutical Sciences. 75(2). 158–160. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard A. Robson Breakdown of academic impact, for papers by G Strohmeyer Breakdown of academic impact, for papers by S B Rosalki Breakdown of academic impact, for papers by Norton J. Greenberger Breakdown of academic impact, for papers by J. Waldenström Breakdown of academic impact, for papers by Eero A. Sotaniemi Breakdown of academic impact, for papers by Burton Combes Breakdown of academic impact, for papers by Yves Horsmans Breakdown of academic impact, for papers by Nicola Carulli Breakdown of academic impact, for papers by Nils Tryding
Rankless by CCL
2026